The US Food and Drug Administration has authorized Tekmira Pharmaceuticals Corp to provide an experimental drug to people with confirmed or suspected Ebola virus infections the Canadian company said Monday Tekmira said it already has provided its drug known as TKMEbola to several patients under emergency protocols and repeated infusions have been well tolerated The company didnt say how many patients have been treated or where the drug was used